1.1 Synthetic Biology as a Profound Transformative Technology

1.2 Tools Revealed Through New Advancements in Adjacent Technologies

1.3 Synthetic Biology Embraces a Wide Spectrum of Genetic Approaches

1.4 Energizing a Broad Spectrum of Industries and Sectors

1.5 Research Focus and Scope: Unveiling Synthetic Biology

1.6 Analysis Framework: Frost & Sullivan’s Core Value

1.7 Research Methodology: Five Steps Toward Success

2.1 Key Elements of Analysis: The ‘SynBio’ Concept

2.2 Brief Overview of Synthetic Biology Developments

2.3 Analysis of the Application Landscape

2.4 Principal Paradigms Reshaping Synthetic Biology

2.5 Rebuilding Synthetic Biology Tools

3.1 The Race to Develop the Optimal Technology Platform

3.2 Leveraging Cutting-Edge Adjacent Technologies

3.3 On the Road of Synthetic Bioinspiration

3.4 Cutting-edge Advances Energizing Synthetic Biology

3.5 Building Scalable Technologies Through New Manufacturing Approaches

3.6 Addressing Therapeutics Needs

3.7 Exploiting Genome Diversification

3.8 Empowering Therapeutics by Re-engineering Biology Circuits

3.9 Re-inventing Biology in the Race for Effective Therapeutics

3.10 Novel Medicines from Synthetic Biology Exploitation

3.11 Best-in-class Platform Technologies Empowering Medicine

4.1 Market Dynamics and Business Opportunities

4.2 Innovations in Synthetic Biology Tools are Increasingly Driving the Market

4.3 Multispectral Technologies Converging to Synthetic Biology Products

4.4 Energizing Diverse Industries and Sectors Worldwide

4.5 Regional Perspectives Reshaping a Global Vision

4.6 Overview of Key Market Segments

5.1 Technology Synergy Reshaping Value Chain

5.2 New Approaches Driving Solutions

5.3 Technology and Business Landscape: Accelerators

5.4 Technology and Business Landscape: Challenges

5.5 Technology Transfer Assessment and Perceptions

5.6 Principal Innovators and Patent Holders

6.1 Funding and Investment Models and Adoption

6.2 Funding Contribution Focus

6.3 Synthetic Biology Funding Trends

6.4 Funding and Investment Distribution by Type

6.5 Public Funding Distribution by Type

6.6 Public and Private Funding by Region

7.1 Technology Maturity Level and Description

7.2 Roadmap Tapping into Technology Synergy

7.3 Business Model Hybridization

7.4 Future Perspective for Synthetic Biology

8.1 Multicriteria Approach for Benchmarking

8.2 Strategic Portfolio Assessment

8.3 Level 1 Criteria: Innovation Development

8.4 Level 1 Criteria: Financial Performance

8.5 Level 1 Criteria: Market Evolution

8.6 Level 2 Criteria: Key Actions for Success

8.7 Analytic Performance Results

8.8 Multicriteria Final Assessment

8.9 Synthetic Biology Technology Platforms to Watch

8.10 Strategic Business Cases

8.11 Critical Success Factors

9.1 Key Industry Influencers

9.2 Key Industry Models

9.3 Key Industry Participants

9.4 Key Industry References

9.5 Key Industry Exemplars

Legal Disclaimer